JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berg, K. A.
Right arrow Articles by Clarke, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berg, K. A.
Right arrow Articles by Clarke, W. P.

Vol. 299, Issue 2, 593-602, November 2001

Differences in Rapid Desensitization of 5-Hydroxytryptamine2A and 5-Hydroxytryptamine2C Receptor-Mediated Phospholipase C Activation

Kelly A. Berg, Brian D. Stout, Saul Maayani and William P. Clarke

Department of Pharmacology, University of Texas Health Science Center, San Antonio, Texas (K.A.B., B.D.S., W.P.C.); and Department of Anesthesiology, Mount Sinai School of Medicine, New York, New York (S.M.)

The serotonin (5-HT)2A and 5-HT2C receptors share a high degree of sequence homology and have very similar pharmacological profiles. Although it is generally believed that the cellular signal transduction mechanisms activated by these receptors are indistinguishable, recent data suggest significant differences in their signaling cascades. In this study we explored differences in the characteristics and mechanisms of rapid desensitization between the 5-HT2A and 5-HT2C receptor systems. For both receptor systems, pretreatment with 5-HT reduced the ability of a maximal concentration of 5-HT to stimulate phospholipase C-mediated inositol phosphate accumulation by about 65%, although the 5-HT2C receptor system was more sensitive to the desensitizing stimulus. Differences in the concentration dependence of the rate constant for desensitization (kdes) suggested different mechanisms of desensitization for the 5-HT2A and 5-HT2C receptor systems. At very high receptor occupancy (>99%), the responsiveness of the 5-HT2A, but not the 5-HT2C, receptor system returned to control levels despite the continued presence of the agonist. This resensitization was dependent upon the activity of protein kinase C (PKC). Agonist-induced desensitization of the 5-HT2A, but not the 5-HT2C, receptor system was reduced by the PKC inhibitors staurosporine and bisindolylmaleimide, and by down-regulation of PKC. In addition, inhibitors of calmodulin (W-7) or of calmodulin-dependent protein kinase II, reduced 5-HT2A, but not 5-HT2C, desensitization. Desensitization of the 5-HT2C, but not the 5-HT2A, receptor system was dependent on G protein receptor kinase activity. These data further emphasize the major differences in the signaling systems coupled to 5-HT2A/2C receptors.


0022-3565/01/2992-0593$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
R. K. Singh, J. Shi, B. W. Zemaitaitis, and N. A. Muma
Olanzapine Increases RGS7 Protein Expression via Stimulation of the Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling Cascade
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 133 - 140.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Shi, B. Zemaitaitis, and N. A. Muma
Phosphorylation of G{alpha}11 Protein Contributes to Agonist-Induced Desensitization of 5-HT2A Receptor Signaling
Mol. Pharmacol., January 1, 2007; 71(1): 303 - 313.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Gavarini, C. Becamel, C. Altier, P. Lory, J. Poncet, J. Wijnholds, J. Bockaert, and P. Marin
Opposite Effects of PSD-95 and MPP3 PDZ Proteins on Serotonin 5-Hydroxytryptamine2C Receptor Desensitization and Membrane Stability
Mol. Biol. Cell, November 1, 2006; 17(11): 4619 - 4631.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. A. Berg, S. Navailles, T. A. Sanchez, Y. M. Silva, M. D. Wood, U. Spampinato, and W. P. Clarke

J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 260 - 268.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. Turner and J. R. Raymond
Interaction of Calmodulin with the Serotonin 5-Hydroxytryptamine2A Receptor: A PUTATIVE REGULATOR OF G PROTEIN COUPLING AND RECEPTOR PHOSPHORYLATION BY PROTEIN KINASE C
J. Biol. Chem., September 2, 2005; 280(35): 30741 - 30750.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. A. Hazelwood and E. Sanders-Bush
His452Tyr Polymorphism in the Human 5-HT2A Receptor Destabilizes the Signaling Conformation
Mol. Pharmacol., November 1, 2004; 66(5): 1293 - 1300.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. J. Damjanoska, B. A. Heidenreich, G. H. Kindel, D. N. D'Souza, Y. Zhang, F. Garcia, G. Battaglia, W. A. Wolf, L. D. Van de Kar, and N. A. Muma
Agonist-Induced Serotonin 2A Receptor Desensitization in the Rat Frontal Cortex and Hypothalamus
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1043 - 1050.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Becamel, S. Gavarini, B. Chanrion, G. Alonso, N. Galeotti, A. Dumuis, J. Bockaert, and P. Marin
The Serotonin 5-HT2A and 5-HT2C Receptors Interact with Specific Sets of PDZ Proteins
J. Biol. Chem., May 7, 2004; 279(19): 20257 - 20266.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Marion, D. M. Weiner, and M. G. Caron
RNA Editing Induces Variation in Desensitization and Trafficking of 5-Hydroxytryptamine 2c Receptor Isoforms
J. Biol. Chem., January 23, 2004; 279(4): 2945 - 2954.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. J. Damjanoska, L. D. Van de Kar, G. H. Kindel, Y. Zhang, D. N. D'Souza, F. Garcia, G. Battaglia, and N. A. Muma
Chronic Fluoxetine Differentially Affects 5-Hydroxytryptamine2A Receptor Signaling in Frontal Cortex, Oxytocin- and Corticotropin-Releasing Factor-Containing Neurons in Rat Paraventricular Nucleus
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 563 - 571.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. Fenik and S. C. Veasey
Pharmacological Characterization of Serotonergic Receptor Activity in the Hypoglossal Nucleus
Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 563 - 569.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Zhang, K. J. Damjanoska, G. A. Carrasco, B. Dudas, D. N. D'Souza, J. Tetzlaff, F. Garcia, N. R. S. Hanley, K. Scripathirathan, B. R. Petersen, et al.
Evidence That 5-HT2A Receptors in the Hypothalamic Paraventricular Nucleus Mediate Neuroendocrine Responses to (-)DOI
J. Neurosci., November 1, 2002; 22(21): 9635 - 9642.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. D. Stout, W. P. Clarke, and K. A. Berg
Rapid Desensitization of the Serotonin2C Receptor System: Effector Pathway and Agonist Dependence
J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 957 - 962.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.